Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D5EP4C
|
|||
| Drug Name |
ION547
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | Thrombosis [ICD-11: DB61-GB90] | Phase 1 | [1] | |
| Company |
Ionis
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Coagulation factor XII (F12) | Target Info | . | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04934891) A Double-Blind, Placebo-Controlled, Dose-Escalation Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ION547 Administered Subcutaneously to Healthy Subjects. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.